131 related articles for article (PubMed ID: 26350192)
1. Molecular detection of human papillomavirus and viral DNA load after radiotherapy for cervical carcinomas.
Kahla S; Kochbati L; Sarraj S; Ben Daya I; Maalej M; Oueslati R
Tumori; 2016 Oct; 102(5):521-526. PubMed ID: 26350192
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus genotype as a major determinant of the course of cervical cancer.
Lombard I; Vincent-Salomon A; Validire P; Zafrani B; de la Rochefordière A; Clough K; Favre M; Pouillart P; Sastre-Garau X
J Clin Oncol; 1998 Aug; 16(8):2613-9. PubMed ID: 9704710
[TBL] [Abstract][Full Text] [Related]
5. Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer.
Song YJ; Kim JY; Lee SK; Lim HS; Lim MC; Seo SS; Kang S; Lee DO; Park SY
Int J Cancer; 2011 Aug; 129(4):896-902. PubMed ID: 21064095
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer.
Combes JD; Pawlita M; Waterboer T; Hammouda D; Rajkumar T; Vanhems P; Snijders P; Herrero R; Franceschi S; Clifford G
Int J Cancer; 2014 Nov; 135(10):2453-61. PubMed ID: 24729277
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, distribution, and viral burden of all 15 high-risk human papillomavirus types in adenosquamous carcinoma of the uterine cervix: a multiplex real-time polymerase chain reaction-based study.
Quddus MR; Manna P; Sung CJ; Kerley S; Steinhoff MM; Lawrence WD
Hum Pathol; 2014 Feb; 45(2):303-9. PubMed ID: 24355194
[TBL] [Abstract][Full Text] [Related]
8. HPV-DNA, vascular space invasion, and their impact on the clinical outcome in early-stage cervical carcinomas.
Graflund M; Sorbe B; Sigurdardóttir S; Karlsson M
Int J Gynecol Cancer; 2004; 14(5):896-902. PubMed ID: 15361201
[TBL] [Abstract][Full Text] [Related]
9. Comparison of oncogenic HPV type-specific viral DNA load and E6/E7 mRNA detection in cervical samples: results from a multicenter study.
Broccolo F; Fusetti L; Rosini S; Caraceni D; Zappacosta R; Ciccocioppo L; Matteoli B; Halfon P; Malnati MS; Ceccherini-Nelli L
J Med Virol; 2013 Mar; 85(3):472-82. PubMed ID: 23280876
[TBL] [Abstract][Full Text] [Related]
10. Influence of HPV type on prognosis in patients diagnosed with invasive cervical cancer.
Cuschieri K; Brewster DH; Graham C; Nicoll S; Williams AR; Murray GI; Millan D; Johannessen I; Hardie A; Cubie HA
Int J Cancer; 2014 Dec; 135(11):2721-6. PubMed ID: 24740764
[TBL] [Abstract][Full Text] [Related]
11. Situation of HPV16 E2 gene status during radiotherapy treatment of cervical carcinoma.
Kahla S; Kochbati L; Maalej M; Oueslati R
Asian Pac J Cancer Prev; 2014; 15(6):2869-73. PubMed ID: 24761916
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus detection in cervical carcinoma tissues and paraaortic lymph nodes by the polymerase chain reaction.
Park JS; Chee YH; Namkoong SE; Han SK; Kim TE; Lee HY; Kim SJ
Gynecol Oncol; 1994 Jun; 53(3):344-51. PubMed ID: 8206408
[TBL] [Abstract][Full Text] [Related]
13. Impact of viral E2-gene status on outcome after radiotherapy for patients with human papillomavirus 16-positive cancer of the uterine cervix.
Lindel K; de Villiers EM; Burri P; Studer U; Altermatt HJ; Greiner RH; Gruber G
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):760-5. PubMed ID: 16682151
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus DNA load and p16INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy.
Rödel F; Wieland U; Fraunholz I; Kitz J; Rave-Fränk M; Wolff HA; Weiss C; Wirtz R; Balermpas P; Fokas E; Rödel C
Int J Cancer; 2015 Jan; 136(2):278-88. PubMed ID: 24839133
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and viral load of oncogenic human papillomavirus (HPV) in pterygia in multi-ethnic patients in the Malay Peninsula.
Chong PP; Tung CH; Rahman NA; Yajima M; Chin FW; Yeng CL; Go ES; Chan CM; Yawata N; Yamamoto N
Acta Ophthalmol; 2014 Nov; 92(7):e569-79. PubMed ID: 25043991
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.
Liu Y; Lu Z; Xu R; Ke Y
Oncotarget; 2016 Feb; 7(5):5852-64. PubMed ID: 26735580
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus and prognosis of invasive cervical cancer: a population-based study.
Schwartz SM; Daling JR; Shera KA; Madeleine MM; McKnight B; Galloway DA; Porter PL; McDougall JK
J Clin Oncol; 2001 Apr; 19(7):1906-15. PubMed ID: 11283122
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus genotype and prognosis of cervical cancer: Favorable survival of patients with HPV16-positive tumors.
Onuki M; Matsumoto K; Tenjimbayashi Y; Tasaka N; Akiyama A; Sakurai M; Minaguchi T; Oki A; Satoh T; Yoshikawa H
Papillomavirus Res; 2018 Dec; 6():41-45. PubMed ID: 30347290
[TBL] [Abstract][Full Text] [Related]
19. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
[TBL] [Abstract][Full Text] [Related]
20. Low initial human papillomavirus viral load may indicate worse prognosis in patients with cervical carcinoma treated with surgery.
Deng T; Feng Y; Zheng J; Huang Q; Liu J
J Gynecol Oncol; 2015 Apr; 26(2):111-7. PubMed ID: 25872892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]